A Study of the Management of Patients Taking Novel Oral Antiplatelet or Direct Oral Anticoagulant Medication Undergoing Dental Surgery in a Rural Setting

Purpose: Novel oral antiplatelet (NOAP) (prasugrel and ticagrelor) and direct oral anticoagulant drugs (DOAC) (dabigatran, rivaroxaban and apixaban) have emerged in the last decade. This study was undertaken to determine current approaches taken to the management of patients taking these agents in d...

Descripción completa

Detalles Bibliográficos
Autor principal: Johnston, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851194/
https://www.ncbi.nlm.nih.gov/pubmed/29567930
http://dx.doi.org/10.3390/dj3040102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851194/
https://www.ncbi.nlm.nih.gov/pubmed/29567930
http://dx.doi.org/10.3390/dj3040102

Ejemplares similares